Our study investigated the frequency of interleukin-6 (IL-6) promoter polymorphism rs1800795 (−174 GNC), possible association of this polymorphism with IL-6 levels and the outcome after stroke in 95 patients with acute ischemic stroke and 268 healthy subjects. It shows a significant reduction in the frequency of G alleles in stroke patients compared to healthy controls. Carriage of G allele is not associated with stroke subtypes, the initial severity or the outcome after stroke. The −174 polymorphisms were not associated with variation in IL-6 levels post-stroke. Our results indicate that IL-6 promoter −174 polymorphisms may play a role in susceptibility to stroke, but not stroke outcome.
Introduction
Acute ischemic stroke arises after interruption of blood flow through an intra-cerebral artery. The etiology can include large artery atherosclerosis, cardioembolism, small vessel occlusion and other causes (Adams et al., 1993) . Interruption of blood supply results early cell death in the center of the stroke (Dirnagl et al., 1999; Moustafa and Baron, 2008; McCombe and Read, 2008) . There is potentially reversible injury in the surrounding tissue if blood supply is restored.
Recently there has been interest in the role of the immune system in stroke (McCombe and Read, 2008) , as immune system plays a role in the pathogenesis of stroke. Locally, the immune system controls the development of atheromatous plaque and plaque rupture (Koenig and Khuseyinova, 2007; Esper et al., 2006; Croce and Libby, 2007; Hansson and Libby, 2006) . When stroke occurs, local inflammation with infiltration of leukocytes always be found surrounding the site of tissue injury (Arumugam et al., 2005; Nilupul et al., 2006) . In the area of the stroke, there are increased levels of interleukin 4 (IL-4), interleukin 10 (IL-10) interleukin 17 (IL-17) and interferon-γ (IFN-γ) mRNA (Li et al., 2001) and transforming growth factor beta (TGF-β) (Doyle et al., 2010) . Increased levels of circulating cytokines, including interleukin-6 (IL-6) (Smith et al., 2004) , TNF-alpha (Vila et al., 2000) , IL-17 (Li et al., 2005) , IL-18 (Vila et al., 2000; Zaremba and Losy, 2003; Al-Bahrani et al., 2007) and IL-10 are also detected (Nayak et al., 2009) . Cytokine levels can remain elevated for up to three weeks after stroke (Yan et al., 2012) . The source of the cytokines in the blood is unclear. It is possible that the cytokines in peripheral blood are released from inflammatory cells, since expression of messenger RNA (mRNA) in peripheral blood cells is increased (Kostulas et al., 1999) . However, another study suggested that peripheral blood cells were not the source of the cytokines in the blood after stroke (Emsley et al., 2007) . In addition, systemic activation of the immune system with increased levels of circulating T cells and B cells has also been reported (Yan et al., 2009 ).
IL-6, which has both pro-and anti-inflammatory properties (Scheller et al., 2011) , is usually released in response to tissue damage and acts on a wide range of target cells (Rincon, 2012) . Elevated serum levels of IL-6 are found after stroke (Kim et al., 2000) , and are correlated with poor outcome (Vila et al., 2000; Waje-Andreassen et al., 2005) and post-stroke infection (Kwan et al., 2013) . Circulating levels of IL-6 have been found to be correlated with infarct size (Smith et al., 2004) and stroke severity (Yan et al., 2012) . One possible aspect affecting IL-6 levels is gender, as male mice have higher levels of IL-6 after burn injury than female mice (Plackett et al., 2010) and male patients have higher levels of IL-6 in serum after trauma (Sperry et al., 2008) . Our previous study found less difference in IL-6 levels between male patients and female patients with acute ischemic stroke (Yan et al., 2012) .
Contribution of genetic polymorphisms to the variation of cytokine level also reported, and the promoter region of IL-6 gene, with the polymorphism at position 174 (−174G bC, rs1800795) is one of the well being most studied. IL-6 −174GbC polymorphisms are reported to be associated with the basal levels of cytokine or the levels of cytokine in response to stimulus. One study indicated that the wild type G allele at position − 174 of the promoter region is dominant in normal subjects; both basal transcription and cytokine levels of IL-6 are higher in subjects carrying G allele (Woo and Humphries, 2013) , whereas in subjects homozygous for the CC polymorphism, levels of IL-6 are reduced (Hoffmann et al., 2001) (Fishman et al., 1998) . However, a E-mail address: p.mccombe@uq.edu.au (M. PA).
